Mithra Pharmaceuticals SA (OTCPK:MITPF)
$ 6.75 0 (0%) Market Cap: 15.66 Mil Enterprise Value: 215.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Q4 2022 Mithra Pharmaceuticals SA Earnings Call Transcript

Mar 07, 2023 / 08:00AM GMT
Release Date Price: $6.75
Operator

Hello, and welcome to Mithra's Full Year 2022 Results Conference Call. My name is Priscilla, and I'll be your coordinator for today's event. Please note this call is being recorded. (Operator Instructions)

I will now hand it over to your host Mr. Benoit Mathieu from Investor Relations to begin today's conference, Please go ahead sir.

Benoit Mathieu
Mithra Pharmaceuticals SA - Group IR Manager

Thank you, Priscilla. Good morning, ladies and gentlemen. My name is Benoit Mathieu, Group Investor Relations Manager. Thank you all for dialing into this conference call and for being with us for the presentation of our full-year results 2022.

I am joined in the room by our CEO, Mr. Leon Van Rompay; Mr. Christophe Marechal, CFO; Mr. Graham Dixon, CSO; Mr. Jean-Manuel Fontaine, Chief Commercial Officer; Professor Jean-Michel Foidart will join the Q&A session in order to answer the questions from the safety results we did a few days ago.

This webcast is recorded and will be accessible later today on Mithra's website. I would like to remind

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot